CompoAtlas

PHYSIONORM PLUS

Food supplement declared in France, declaration No 2016-10-789, decision dated 20 October 2016

PHYSIONORM PLUS is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 1 point in its composition requires a check (prohibited substance, dose or novel food).

Brand
not provided
Food business operator placing the product on the market
LABORATOIRE IMMUBIO
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Gélule
Daily dose
2 gélules
Directions for use
2 gélules en 1 fois le 1er jour;1 gélule le matin et 1 le soir les 2 jours suivants

Declaration 276789, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Other active ingredients

NamePer day
dextrinenot declared

Micro-organisms

StrainPer day
cerevisiae boulardii Saccharomyces I-3799 / CBS 59265,000,000,000 (unit not declared)
Lactobacillus Acidophilus IN-01514,800,000,000 (unit not declared)
Lactobacillus Casei HA-1082,400,000,000 (unit not declared)
Streptococcus Thermophilus HA-110800,000,000 (unit not declared)

Additives

Hydroxypropyl Méthyl Cellulose, E341, E300, E470b, E551, E171

Other ingredients

maltodextrine

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

List recorded in 2016. Photograph the packaging to check whether it has changed.

Has the product changed? Photograph the packaging.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

List recorded in 2016. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line